An Open-Label Phase II Study of Lenvatinib Plus Pembrolizumab in Patients with Advanced Gastric Cancer (EPOC1706).Akihito Kawazoe,Shota Fukuoka,Yoshiaki Nakamura,Yasutoshi Kuboki,Yuichi Mikamoto,Hikari Shima,Noriko Fujishiro,Tsukiko Higuchi,Masashi Wakabayashi,Shogo Nomura,Akihiro Sato,Kohei ShitaraJournal of clinical oncology（2020）引用 8|浏览59暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
